| Name | Title | Contact Details |
|---|---|---|
Matt Pendley |
Executive Director, Customer/Partner Finance | Profile |
Christopher Young |
Vice President of Corporate Training and Development | Profile |
Ophthotech is a biopharmaceutical company specializing in the development of novel therapeutics to treat back of the eye diseases, with a focus on developing innovative therapies for age-related macular degeneration (AMD). Ophthotech`s most advanced product candidate, Fovista® anti-PDGF therapy, is in Phase 3 clinical trials for use in combination with anti-VEGF therapy that represents the current standard of care for the treatment of wet AMD. Ophthotech`s second product candidate, Zimura®, an inhibitor of complement factor C5, is being developed for the treatment of geographic atrophy, a form of dry AMD.
Vista Pharmaceuticals is a West Orange, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Hillcrest Atrium Pharmacy is a Cleveland, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Dyancon is a Mississauga, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Adjuvants Plus Inc is a Kingsville, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.